Articles
Scientist gets his mind around Alzheimer’s
It’s not known what causes the disease or how to cure it. And the stakes have never been higher. But one European neuroscientist is leading...
Drug Research
Lycera Announces Research Collaboration with Merck
Lycera Corporation, a biopharmaceutical company pioneering innovative approaches to developing novel oral medicines to treat autoimmune diseases, announced that it has entered into an exclusive...
Drug Research
Shire Strengthens Specialty Pharmaceuticals Team with Senior R&D Appointments
Shire plc, the global specialty biopharmaceutical company, today announced the appointment of two senior Research & Development executives to its Specialty Pharmaceuticals business. Lawson Macartney,...
Articles
Maximising Drug Discovery Research
Interview with: Teodor Aastrup, Chief Executive Officer, Attana AB "Drug discovery scientists should focus on the biological relevance of their candidate molecules...
Drug Research
King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New...
King Pharmaceuticals®, Inc. and Pain Therapeutics®, Inc. announced that King has resubmitted a New Drug Application (NDA) for REMOXY® (oxycodone) to the U.S. Food and...
Drug Research
King Pharmaceuticals and Acura Pharmaceuticals Announce Submission of New...
King Pharmaceuticals®, Inc. and Acura Pharmaceuticals, Inc. announced that King has submitted a New Drug Application (NDA) for ACUROX® (oxycodone HCl) Tablets to the U.S....
Drug Research
Pfizer Announces Phase 3 Results of Investigational Compound Bosutinib
Pfizer Inc. announced that a significantly higher proportion of patients with newly diagnosed chronic myeloid leukemia who were treated with bosutinib (39 percent) experienced a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.